Introduction: Managing Bipolar Depression

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Bipolar disorder can be found in 1.2% to 3.4% of the general population.1 Patients with bipolar disorder attempt suicide at a higher rate than patients with other psychiatric disorders, exhibit substantially more depressive symptoms than manic or hypomanic symptoms,2,3 are at risk for relapse into subsequent bipolar episodes, suffer from subsyndromal symptoms that interfere with functioning and quality of life, and frequently do not respond adequately to standard treatment. Lithium, valproate, and carbamazepine remain the standard of care for the treatment of bipolar disorder, and the U.S. Food and Drug Administration has approved the use of lithium for the treatment of both acute episodes of mania and maintenance therapy in bipolar disorder and the use of the anticonvulsant lamotrigine and the atypical antipsychotic olanzapine for maintenance therapy.​​

J Clin Psychiatry 2004;65(suppl 10):3-4